Save time and jump to the most important pieces.
Date | Price Target | Rating | Analyst |
---|---|---|---|
12/17/2024 | $45.00 → $43.00 | Neutral → Underweight | Analyst |
12/16/2024 | $50.00 → $45.00 | Buy → Hold | Truist |
12/6/2024 | Hold | Needham | |
11/25/2024 | $48.00 | Outperform | Exane BNP Paribas |
11/6/2024 | $50.00 → $48.00 | Buy → Hold | TD Cowen |
9/30/2024 | $43.00 → $53.00 | Equal Weight → Overweight | Barclays |
4/2/2024 | $52.00 | Sell → Neutral | Citigroup |
1/29/2024 | $68.00 → $58.00 | Overweight → Equal-Weight | Morgan Stanley |
Analyst downgraded Brown-Forman from Neutral to Underweight and set a new price target of $43.00 from $45.00 previously
Truist downgraded Brown-Forman from Buy to Hold and set a new price target of $45.00 from $50.00 previously
Needham initiated coverage of Brown-Forman with a rating of Hold
4 - BROWN FORMAN CORP (0000014693) (Issuer)
3 - BROWN FORMAN CORP (0000014693) (Issuer)
4 - BROWN FORMAN CORP (0000014693) (Issuer)
SC 13G/A - BROWN FORMAN CORP (0000014693) (Subject)
SC 13G/A - BROWN FORMAN CORP (0000014693) (Subject)
SC 13G/A - BROWN FORMAN CORP (0000014693) (Subject)
8-K - BROWN FORMAN CORP (0000014693) (Filer)
8-K - BROWN FORMAN CORP (0000014693) (Filer)
10-Q - BROWN FORMAN CORP (0000014693) (Filer)